Prescription Status and Clinical Outcomes of Methylxanthines and Leukotriene Receptor Antagonists in Mild-to-Moderate Chronic Obstructive Pulmonary Disease

BACKGROUND: Methylxanthines and leukotriene receptor antagonists (LTRA) are not a first-line medical treatment for chronic obstructive pulmonary disease (COPD) but are frequently prescribed despite limited evidence. We aimed to elucidate the real prescribing status and clinical impacts of these agen...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jung-Kyu, Rhee, Chin Kook, Kim, Kyungjoo, Ra, Seung Won, Lee, Jae Ha, Jung, Ki-Suck, Yoo, Kwang Ha, Kim, Yoo-Il, Kim, Deog Kyeom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885559/
https://www.ncbi.nlm.nih.gov/pubmed/31819397
http://dx.doi.org/10.2147/COPD.S216326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885559/
https://www.ncbi.nlm.nih.gov/pubmed/31819397
http://dx.doi.org/10.2147/COPD.S216326

Ejemplares similares